The signature event in Cambridge Healthtech Institute's Biomarker Series, the Tenth Annual Biomarkers & Diagnostics World Congress 2014 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers. Now in its tenth year, the Biomarkers & Diagnostics World Congress is the leading annual meeting dedicated to biomarker and diagnostics research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.
The World Congress will continue offering a comprehensive coverage of biomarkers in drug development, including translational biomarkers, patient selection and drug-diagnostic co-development. The Executive Summit on Companion Diagnostics is designed to bring together drug development and diagnostics leaders to brainstorm strategies for Rx-Dx co-development, including reimbursement, regulatory, and technology/implementation strategies. A new track on Laboratory-Developed Tests will follow the Clinical Biomarker Assay Development track, for complete coverage on biomarker assay development technologies, regulation, and clinical utility. Finally, a new track on Mutation Analysis for Clinical Biomarkers and Diagnostics will cover the recent research and technologies related to genomic analysis to guide clinical decision making. Please join us for comprehensive scientific coverage and unparallel networking opportunities at the Tenth Anniversary Congress!